Skip to main content

Part of the book series: Basic Life Sciences ((BLSC,volume 50))

  • 56 Accesses

Abstract

There is a consensus that previous difficulties encountered in U.S. clinical trials of NCT resulted from the use of inorganic compounds showing no tumor selectivity, and the use of thermal neutron beams which are known to have poor penetration in tissue (HVL ≈ 1.8 cm). Consequently, normal surface tissues were over-exposed, while viable tumor remained at depth. Since then, these problems have been largely circumvented through the development of epithermal neutron beams with better tissue penetration, and the synthesis of various boronated biomolecules which demonstrate tumor selectivity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. T. Kobayashi and K. Kanda, Analytical calculation of boron -10 dosage in cell nucleus for neutron capture therapy, Radiat. Res. 91: 77 (1982).

    Article  PubMed  CAS  Google Scholar 

  2. D. Gabel, S. Foster, and R. G. Fairchild, The Monte-Carlo simulation of the biological effect of the 10B(Nna)7Li reaction in cells and tissue and its implication for boron neutron capture therapy, Radiat. Res. 111: 14 (1987).

    CAS  Google Scholar 

  3. B. J. Hall, “Radiobiology for the Radiologist,” Harper and Rowe, New York (1986).

    Google Scholar 

  4. B. S. Hilaris, ed., “Handbook of Interstitial Brachytherapy”, Publishing Science Group Inc., Criton, MA (1975).

    Google Scholar 

  5. H. Hatanaka, ed., “Boron Neutron Capture Therapy for Tumors,” Nishimura Co., Ltd., Japan (1986).

    Google Scholar 

  6. R. G. Fairchild and L. J. Goodman, Development and dosimetry of an “epithermal” neutron beam for possible use in neutron capture therapy. II. Absorbed dose measurements in a phantom man, Phys. Med. Biol. 11: 15 (1966).

    Article  CAS  Google Scholar 

  7. R. G. Fairchild and V. P. Bood, Current status of neutron capture therapy: Enhancement of tumor dose viabeam filtration and dose rate, and the effects of these parameters on minimum boron content: A theoretical evaluation, Int. J. Radiat. Oncol. Biol. Phys. 11: 831 (1985).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Fairchild, R.G. (1989). Dose Rate and Therapeutic Gain. In: Fairchild, R.G., Bond, V.P., Woodhead, A.D., Vivirito, K. (eds) Clinical Aspects of Neutron Capture Therapy. Basic Life Sciences, vol 50. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5622-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5622-6_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5624-0

  • Online ISBN: 978-1-4684-5622-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics